Herpes Simplex Virus 1+2 IgA Control Serum BC105A

$94.00

Summary

Virion/Serion Diagnostic Kit Control for research use (RUO)
Herpes Simplex Virus (HSV) 1+2 IgA Control Serum
Applications: ELISA
IgA control serum
Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
3 mL

SKU: BC105A Categories: control serum, Virion/Serion kits Tags: ELISA control serum, Herpes simplex Virus, IgA

Weight	1 lbs
Dimensions	9 × 5 × 2 in
target	Herpes Simplex Virus 1+2 reactive IgA
species reactivity	Herpes Simplex Virus
applications	ELISA
assay type	Indirect & quantitative
available size	3 mL

Herpes Simplex Virus 1+2 IgA Control Serum BC105A

kit
Research area Infectious Disease
Storage Store at 2-8°C.
Associated products Herpes Simplex Virus 1+2 IgA Control Serum (BC105A) Herpes Simplex Virus 1+2 IgG Control Serum (BC105G) Herpes Simplex Virus 1+2 IgM Control Serum (BC105M) Herpes simplex Virus 1 and 2 IgA ELISA Kit (ESR105A) Herpes simplex Virus 1 and 2 IgG ELISA Kit (ESR105G) Herpes simplex Virus 1 and 2 IgM ELISA Kit (ESR105M)

target relevance

human antibody anti-Herpes Simplex Virus (HSV)

Herpes Simplex Virus (HSV)

Description
Virus that causes oral herpes, genital herpes, and other mucocutaneous infections

Structure
Herpes simplex viruses (HSV) are enveloped, double-stranded DNA viruses belonging to the genus Simplexvirus within the family Herpesviridae. Two closely related species, Herpes simplex virus type 1 (HSV-1) and Herpes simplex virus type 2 (HSV-2), are responsible for the majority of human infections. The viral genome is enclosed within an icosahedral capsid surrounded by a protein tegument and a lipid envelope containing glycoproteins that mediate attachment and entry into host cells. Following primary infection, HSV establishes lifelong latency within sensory neurons, particularly in the trigeminal and sacral ganglia. Periodic reactivation of latent virus results in recurrent infections and viral shedding, often in the absence of symptoms. HSV infections are widespread globally and represent some of the most common viral infections of humans.

Diagnosis
The diagnosis of herpes simplex virus infection is performed through clinical evaluation and laboratory testing. Molecular methods such as polymerase chain reaction (PCR) are highly sensitive and specific and are considered the preferred diagnostic approach for detecting HSV DNA in lesion swabs, cerebrospinal fluid, and other clinical specimens. Viral culture may also be used, particularly for active lesions, although it is generally less sensitive than PCR. Direct fluorescent antibody testing and antigen detection assays may provide rapid identification in selected settings. Serological assays, including ELISA-based tests, can detect HSV-specific antibodies and help distinguish previous exposure to HSV-1 and HSV-2. Laboratory confirmation is particularly important in cases of neonatal herpes, encephalitis, and atypical presentations.

Symptoms
Herpes simplex virus infections produce a wide range of clinical manifestations depending on the site of infection and immune status of the host. Primary infection may be asymptomatic or may present with painful vesicular lesions involving the oral cavity, lips, genital region, skin, or eyes. HSV-1 most commonly causes oral herpes characterized by fever, gingivostomatitis, and recurrent cold sores, whereas HSV-2 is more frequently associated with genital herpes causing painful ulcers, itching, dysuria, and regional lymphadenopathy. Recurrent episodes are typically milder than primary infections due to partial immune control. In immunocompromised individuals and neonates, HSV can cause severe disseminated disease. Rare but serious complications include herpes encephalitis, keratitis leading to vision loss, meningitis, and neonatal herpes, which may be life-threatening if untreated.

Data

FAQ & Publications

Frequently Asked Questions

What is the intended application of the Herpes Simplex Virus 1+2 IgA Control Serum BC105A?

The Herpes Simplex Virus 1+2 IgA Control Serum BC105A is designed for use as a control serum in ELISA applications, specifically for indirect and quantitative assays detecting IgA antibodies against HSV 1 and 2.

How should the Herpes Simplex Virus 1+2 IgA Control Serum BC105A be stored to maintain its stability?

This control serum should be stored refrigerated at 2-8°C to preserve its integrity and ensure reliable performance.

Is the Herpes Simplex Virus 1+2 IgA Control Serum BC105A compatible with specific ELISA kits?

Yes, the serum is ready-to-use and pre-diluted for compatibility with SERION ELISA classic and SERION ELISA antigen assays.

Which viral targets are recognized by the Herpes Simplex Virus 1+2 IgA Control Serum BC105A?

The serum contains IgA antibodies reactive to Herpes Simplex Virus types 1 and 2, targeting antigens from both HSV-1 and HSV-2 strains.

Publications

pmid	title	authors	citation
We haven't added any publications to our database yet.

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.

Protocols

relevant to this product
BC105A protocol

Documents

#
Please enter your product and batch number here.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Herpes Simplex Virus 1+2 IgA Control Serum BC105A

Data

FAQ & Publications

Protocols

Documents

Related Technical Resources & Posts

Reviews

Related Products

Candida albicans IgA Control Serum BC117A

Herpes Simplex Virus 2 gP IgG Control Serum BC1052G

Campylobacter jejuni IgA Control Serum BC139A

Herpes Simplex Virus 1+2 IgG Control Serum BC105G

Brucella IgA Control Serum BC116A

Herpes Simplex Virus 1 gP IgG Control Serum BC1051G

Bordetella pertussis IgA Control Serum BC120A

Herpes Simplex Virus 1 IgM Control Serum BC1051M

Adenovirus IgA Control Serum BC128A

Helicobacter pylori IgA Control Serum BC118A

Enterovirus IgA Control Serum BC133A

Echovirus IgA Control Serum BC135A

Coxsackie IgA Virus Control Serum BC134A

Chlamydia trachomatis IgA Control Serum BC1372A

Chlamydia pneumoniae IgA Control Serum BC1371A